Dongkoo Bio&Pharma Co Ltd

006620

Company Profile

  • Business description

    Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

  • Contact

    B-14F, M State Building, 114, Beobwonro, Songpagu
    Seoul05836
    KOR

    T: +82 226845421

    http://www.dongkoo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    446

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,236.906.40-0.07%
CAC 408,135.7469.060.86%
DAX 4024,567.14255.65-1.03%
Dow JONES (US)48,985.9129.69-0.06%
FTSE 10010,263.34108.911.07%
HKSE27,968.09141.180.51%
NASDAQ23,817.7239.72-0.17%
Nikkei 22553,375.6016.890.03%
NZX 50 Index13,348.6164.26-0.48%
S&P 5006,986.238.200.12%
S&P/ASX 2008,927.504.300.05%
SSE Composite Index4,157.986.750.16%

Market Movers